Abstract
In the HELP OLE, attack-free periods of ≥6 months and ≥12 months were achieved by 81.8% and 68.9% of patients in the overall population, respectively (regular dosing period for rollovers). Herein we analyze the attack-free status for patients treated for ≥12 months.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
